Tech Company Financing Transactions

Moma Therapeutics Funding Round

Goldman Sachs, Alexandria Venture Investments and Casdin Capital participated in a $150 million Series B capital raise for Moma Therapeutics. This venture round was announced on 5/10/2022.

Transaction Overview

Company Name
Announced On
5/10/2022
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series B
Proceeds Purpose
Proceeds to fund the advancement of multiple precision oncology programs toward the clinic

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
215 1st St. 150
Cambridge, MA 02142
USA
Email Address
Overview
We're on a mission to unlock molecular machines by understanding and respecting their complexities. We'll be working incredibly hard to discover their untapped potential because we believe they are the key to delivering the next generation of precision medicines.
Profile
Moma Therapeutics LinkedIn Company Profile
Social Media
Moma Therapeutics Company Twitter Account
Company News
Moma Therapeutics News
Facebook
Moma Therapeutics on Facebook
YouTube
Moma Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Reid Huber
  Reid Huber LinkedIn Profile  Reid Huber Twitter Account  Reid Huber News  Reid Huber on Facebook
Chief Operating Officer
Walt Kowtoniuk
  Walt Kowtoniuk LinkedIn Profile  Walt Kowtoniuk Twitter Account  Walt Kowtoniuk News  Walt Kowtoniuk on Facebook
Chief Scientific Officer
Christoph Lengauer
  Christoph Lengauer LinkedIn Profile  Christoph Lengauer Twitter Account  Christoph Lengauer News  Christoph Lengauer on Facebook
Vice President
Timothy Guzi
  Timothy Guzi LinkedIn Profile  Timothy Guzi Twitter Account  Timothy Guzi News  Timothy Guzi on Facebook
VP - Product Management
Sarah Larson
  Sarah Larson LinkedIn Profile  Sarah Larson Twitter Account  Sarah Larson News  Sarah Larson on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/10/2022: Abnormal Security venture capital transaction
Next: 5/10/2022: Domain Therapeutics venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary